Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Income from Continuing Operations (2017 - 2025)

Selectis Health's Income from Continuing Operations history spans 14 years, with the latest figure at 502660.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 69.41% year-over-year to 502660.0; the TTM value through Sep 2025 reached 2596331.0, up 67.52%, while the annual FY2024 figure was 4776085.0, 57.1% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 502660.0 at Selectis Health, up from 676280.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 987560.0 in Q2 2022 and bottomed at 3673152.0 in Q4 2023.
  • The 5-year median for Income from Continuing Operations is 1326594.0 (2024), against an average of 1252344.05.
  • The largest annual shift saw Income from Continuing Operations tumbled 1451.62% in 2021 before it skyrocketed 252.37% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 1979715.0 in 2021, then dropped by 12.4% to 2225180.0 in 2022, then tumbled by 65.07% to 3673152.0 in 2023, then surged by 87.67% to 452978.0 in 2024, then fell by 10.97% to 502660.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Income from Continuing Operations are 502660.0 (Q3 2025), 676280.0 (Q2 2025), and 964413.0 (Q1 2025).